Knollwood Investment Advisory’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32,174	Closed	-$209K	–	138
2023 Q1	$209K	Hold	32,174	–	–	0.04%	127
2022 Q4	$274K	Buy	+32,174	New	+$274K	0.11%	107